Session » Osteoarthritis and Joint Biology – Basic Science Poster I
- 9:00AM-11:00AM
-
Abstract Number: 1034
A Conplastic Mice Model of Aging Reveals That Mitochondrial DNA Variation Influences the Process of Joint Deterioration
- 9:00AM-11:00AM
-
Abstract Number: 1044
Alendronate-CGS21680 Conjugates Prevent Bone Erosion in a Murine Osteolysis Model
- 9:00AM-11:00AM
-
Abstract Number: 1033
Comparison of Oral Administration of Diacerein, Intra-Articular Injection of Diacerein Solution, and Intra-Articular Injection of Diacerein-Loaded Nanoparticle in Osteoarthritis Rat Model
- 9:00AM-11:00AM
-
Abstract Number: 1043
Computational Analysis of Potential Self-Antigens in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1052
Detection of Precursors of RANK- Osteoclast-like Cells (Olcs) in Peripheral Blood and Olcs in Bone Tissue from Rheumatoid Arthritis Patients
- 9:00AM-11:00AM
-
Abstract Number: 1037
Develop an in Vitro Model to Test the Different Behavior of mtDNA in OA and Healthy Patients, Based on Mitochondrial Activity and Metabolic Response
- 9:00AM-11:00AM
-
Abstract Number: 1042
Development of a Neo-Epitope Specific Assay for Serological Assessment of Type X Collagen Degradation and Its Potential Diagnostic Value for Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1035
Different Cartilage-Bone Unit in Patients with Primary Osteoarthritis and Secondary Osteoarthritis Caused By Rheumatoid Arthritis
- 9:00AM-11:00AM
-
Abstract Number: 1046
Distinct Balance of TNF-α/IL-10 in Circulating and Infiltrating CD163+ Macrophages between Rapidly and Slowly Progressive Symptomatic Knee Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1036
Effects of Three Potential Anabolic Disease-Modifying Osteoarthritis Drugs – Sprifermin, Insulin-like Growth Factor 1 and Bone Morphogenetic Protein 7 – on Matrix Production and the Phenotype of Articular Chondrocytes
- 9:00AM-11:00AM
-
Abstract Number: 1051
Hoxd Genes Regulate Arthritis-Relevant Pathways
- 9:00AM-11:00AM
-
Abstract Number: 1048
Identification of Novel Molecules with Senolytic and Autophagy Activity As Osteoarthritis Therapeutics
- 9:00AM-11:00AM
-
Abstract Number: 1049
Optical Biomarkers for the Early Diagnosis of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1050
Pharmacokinetic and pharmacodynamic modelling of the novel anti-ADAMTS-5 nanobody M6495 using the neo-epitope ARGS as a biomarker
- 9:00AM-11:00AM
-
Abstract Number: 1047
Signaling at Adenosine A2A Receptor (A2aR) in Osteoblasts; Crosstalk with Wnt/ β-Catenin Signaling Pathway
- 9:00AM-11:00AM
-
Abstract Number: 1054
Study of the Metabolic Effect of MSCs on Their Chondroprotective and Regenerative Properties: Modulating Their Metabolism to Improve Their Therapeutic Potential for the Treatment of Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1053
Synovial Inflammation Identifies Patients Clusters in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1039
Tenofovir Induces Osteopenia and Dipyridamole, an Inhibitor of the Ent-1 Nucleoside Transporter, Reverses the Osteopenic Effect of Tenofovir In Vivo
- 9:00AM-11:00AM
-
Abstract Number: 1038
Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine
- 9:00AM-11:00AM
-
Abstract Number: 1041
The Anti-Adamts-5 Nanobody®, M6495, Protects Against Cartilage Breakdown in Cartilage and Synovial Joint Tissue Explant Models
- 9:00AM-11:00AM
-
Abstract Number: 1045
The Coll2-1 Peptide of Collagen Type II: A New Actor of Synovitis in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1040
The Potential Role of Choline Kinase Alpha in Osteoarthritis
- 9:00AM-11:00AM
-
Abstract Number: 1055
The TLR-4 Inhibitor 6-Shogaol As a Treatment in Osteoarthritis Trough the Modulation of Chondrocyte Hypertrophy and Matrix Calcification